FDA Approves Pradaxa for Children

FDA Approves Pradaxa for Children
Jun 23, 2021 2:12pm

Thanks to Dean Willett, Precision BioLogic Inc., for today's heads-up for this FDA announcement [click] approving dabigatran etixalate [Pradaxa®] therapy for children 3 months–12 years who have experienced venous thromboembolic disease.

0 Comments

Leave A Comment

You must be logged in to Comment - Sign In